Benjamin Kowalski
About Benjamin Kowalski
Benjamin Kowalski is the Market Access and Governmental Affairs Executive Director at Bristol Myers Squibb in France, with extensive experience in market access and a diverse educational background.
Market Access and Governmental Affairs Executive Director at Bristol Myers Squibb
Benjamin Kowalski holds the position of Market Access and Governmental Affairs Executive Director at Bristol Myers Squibb in France. In this role, he is responsible for leading efforts to ensure that patients have timely access to the company's innovative therapies. His duties likely involve navigating complex regulatory landscapes and collaborating with governmental bodies to optimize market strategies.
Previous Role at The Janssen Pharmaceutical Companies of Johnson & Johnson
Benjamin Kowalski served as the Pricing and Economic Affairs Director at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2019 to 2021. During his tenure in France, he focused on pricing strategies and economic assessments to support the availability of Janssen's pharmaceutical products. His expertise contributed to the company's market positioning and financial models.
Regional Market Access Manager EMEA at Janssen EMEA
From 2018 to 2019, Benjamin Kowalski was employed as the Regional Market Access Manager for Europe, Middle East, and Africa (EMEA) at Janssen EMEA. Based in Île-de-France, he specialized in market access for bladder and lung cancer therapies. His role involved coordinating market access strategies across diverse healthcare markets, ensuring alignment with local regulations and payer requirements.
Market Access Manager at Janssen France
Benjamin Kowalski worked as the Market Access Manager for multiple myeloma at Janssen France from 2010 to 2018. Located in Issy-les-Moulineaux, he played a pivotal role in developing and implementing market access strategies for multiple myeloma treatments. His contributions helped facilitate market entry and access for novel therapies in France.
Audit Manager at Deloitte
Before joining the pharmaceutical industry, Benjamin Kowalski served as an Audit Manager at Deloitte from 2004 to 2010. His six-year tenure involved overseeing financial audits and ensuring compliance with regulatory standards. This experience provided him with a strong foundation in financial analysis and corporate governance.
Educational Background
Benjamin Kowalski's educational journey is diverse and extensive. He holds a Diplôme Supérieur de Comptabilité et de Gestion, which he completed in 2008. He graduated from HEC Paris in 2004, where he studied for four years. Additionally, he studied at Université Paris-Sorbonne, achieving two Licences in 2000 in French Language and Literature, Latin, ancient Greek, and Histoire. He also attended Hypokhâgne & Khâgne, where he studied French, Latin, ancient Greek, History, Philosophy, and English for three years starting in 1997.